Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Financial Instruments

v3.19.2
Financial Instruments
6 Months Ended
Jun. 30, 2019
Financial Instruments [Abstract]  
FINANCIAL INSTRUMENTS

Note 4 - FINANCIAL INSTRUMENTS

 

The Company’s financial liabilities are measured at fair value with corresponding changes in fair value recognized in the consolidated statements of comprehensive loss as the obligation for warrants and anti-dilution provisions therein are considered to be financial derivatives.

 

The following table presents the Company’s financial liabilities measured at fair value, net of unrecognized day-one losses:

 

    June 30,     December 31,  
    2019     2018  
    U.S. dollars
in thousands
 
Fair value of warrants     1,145       1,263  
Unrecognized day one loss     (572 )     (614 )
Warrants, net     573       649  
                 
Anti-dilution derivatives     327       97